A Novel Inflammation-Marker-Based Prognostic Model for Advanced Pulmonary Lymphoepithelioma-Like Carcinoma
This study established and validated a prognostic nomogram model for patients with advanced PLELC. Combining the nomogram with EBV DNA more effectively predicted the prognosis of patients than the nomogram alone. Immunotherapy was found to be a critical treatment option for PLELC.
Authors
- Yuanyuan Zhao (ORCID: https://orcid.org/0000-0002-7148-7608)
- Silang Mo
- Ting Zhou (ORCID: https://orcid.org/0000-0002-4685-3055)
- Gang Chen (ORCID: https://orcid.org/0000-0001-7713-2413)
- Li Zhang (ORCID: https://orcid.org/0000-0003-0595-0761)
- Xiang Chen (ORCID: https://orcid.org/0000-0002-3371-0055)
- Tingting Liu (ORCID: https://orcid.org/0000-0002-8168-6117)
- Yuanzheng Ma (ORCID: https://orcid.org/0000-0002-9143-1468)
- Yuxiang Ma (ORCID: https://orcid.org/0000-0003-1173-8441)
- Yang Yuwen
- Yaxiong Zhang (ORCID: https://orcid.org/0000-0002-3632-0300)
- Xueyuan Chen (ORCID: https://orcid.org/0000-0003-0493-839X)
- Shaodong Hong
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/jir.s502286
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52